ResearcherThe University of OsakaNo recent work listed

Kosuke Taketo

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5082304388. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2018: 1 paper

Papers 1

The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells. Co-author DOI 10.3892/ijo.2017.4219 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ayumu Asai · 1 shared paper, 2018 · strength 0.08
- Paper The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells. DOI 10.3892/ijo.2017.4219 ↗
Yuichiro Doki · 1 shared paper, 2018 · strength 0.08
- Paper The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells. DOI 10.3892/ijo.2017.4219 ↗
Kazuhiko Ogawa · 1 shared paper, 2018 · strength 0.08
- Paper The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells. DOI 10.3892/ijo.2017.4219 ↗
Hideshi Ishii · 1 shared paper, 2018 · strength 0.08
- Paper The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells. DOI 10.3892/ijo.2017.4219 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.